Cells with BRCA1/2 mutation have an impaired ability to repair DSBs via HR, which is conservative, and potentially error-free, resulting in increased genomic instability and the predisposition to ovarian cancer [2]. The gene discussed is BRCA1; the disease is ovarian cancer.